Companies: 10,795·Total market cap: $144.5T
CTT Pharmaceutical Holdings, Inc.

CTT Pharmaceutical Holdings, Inc.

CTTHOTCHealthcare● Active
$0.08
+$0.00(+0.00%)
Market Cap$1663087
P/E Ratio
52W High$0.1
52W Low$0.017
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

CTT Pharmaceutical Holdings, Inc. (CTTH) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001035422 · CTTH · OTC · as of Jun 9, 2026

Filing snapshot

388
Total Filings
S-1/A
Latest Form
2026-05-29
Most Recent
1997
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001035422 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2015-10-08
Fiscal Year End
Oct 8, 2015
Accession No.
0001553350-15-001055
Primary Document
mdst_10k.htm
Source: data.sec.gov · CIK 0001035422 · Accession 0001553350-15-001055

Latest Key Filings

6-KQuarterly Report

No recent filings

8-KCurrent Report
AMENDED CURRENT REPORT
2016-02-24Material Event
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
S-1/AS-1/A
S-1/A
2026-05-29
View
S-1/AS-1/A
S-1/A
2026-04-15
View
S-1IPO Registration Statement
IPO Registration Statement
2025-12-30
View
15-12G15-12G
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
2016-03-29
View
8-K/ACurrent Report (Amended)
AMENDED CURRENT REPORT
2016-02-24
View
8-KCurrent Report
CURRENT REPORT
2016-02-11
View
UPLOADUPLOAD
UPLOAD
2015-11-30
View
10-QQuarterly Report
QUARTERLY REPORT
2015-11-23
View
10-Q/AQuarterly Report (Amended)
AMENDED QUARTERLY REPORT
2015-11-18
View
NT 10-QNT 10-Q
NOTIFICATION OF LATE FILING
2015-11-16
View
10-Q/AQuarterly Report (Amended)
AMENDED QUARTERLY REPORT
2015-11-12
View
CORRESPCORRESP
CORRESP
2015-11-05
View
8-KCurrent Report
CURRENT REPORT
2015-11-03
View
UPLOADUPLOAD
UPLOAD
2015-10-20
View
CORRESPCORRESP
CORRESP
2015-10-09
View
Showing 1–15 of 301 filingsForm 4 / 144 hidden· 388 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001035422  |  Exchange: OTC · Healthcare

CTT Pharmaceutical Holdings, Inc. (OTC: CTTH) has submitted 388 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1997. As a Healthcare sector company with CIK 0001035422, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is CTT Pharmaceutical Holdings, Inc.'s most comprehensive regulatory disclosure. The most recent CTT Pharmaceutical Holdings, Inc. 10-K was filed on 2015-10-08 for fiscal year ending 2015. Historical CTTH 10-K annual reports are available from 2000 through 2015.

Investors researching CTT Pharmaceutical Holdings, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09

Frequently Asked Questions

CTTH SEC Filings · 8 questions

CTT Pharmaceutical Holdings, Inc. (CTTH) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 388 filings and access original documents at no cost. CTT Pharmaceutical Holdings, Inc.'s CIK is 0001035422.

CTTH SEC filingsCTT Pharmaceutical Holdings, Inc. SEC documentsfind CTTH 10-K